Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Improving work for the body - a participatory ergonomic intervention aiming at reducing physical exertion and musculoskeletal pain among childcare workers (the TOY-project): study protocol for a wait-list cluster-randomized controlled trial.

Rasmussen CDN, Hendriksen PR, Svendsen MJ, Ekner D, Hansen K, Sørensen OH, Svendsen SW, van der Beek AJ, Holtermann A.

Trials. 2018 Jul 31;19(1):411. doi: 10.1186/s13063-018-2788-z.

2.

Can illegitimate job tasks be reduced by a participatory organizational-level workplace intervention? Results of a cluster randomized controlled trial in Danish pre-schools.

Framke E, Sørensen OH, Pedersen J, Rugulies R.

Scand J Work Environ Health. 2018 Mar 1;44(2):219-223. doi: 10.5271/sjweh.3683. Epub 2017 Oct 27.

PMID:
29075782
4.

Effect of a participatory organizational-level occupational health intervention on short-term sickness absence: a cluster randomized controlled trial.

Framke E, Sørensen OH, Pedersen J, Rugulies R.

Scand J Work Environ Health. 2016 May 1;42(3):192-200. doi: 10.5271/sjweh.3559. Epub 2016 Apr 5.

5.

The Danish national return-to-work program--aims, content, and design of the process and effect evaluation.

Aust B, Helverskov T, Nielsen MB, Bjorner JB, Rugulies R, Nielsen K, Sørensen OH, Grundtvig G, Andersen MF, Hansen JV, Buchardt HL, Nielsen L, Lund TL, Andersen I, Andersen MH, Clausen AS, Heinesen E, Mortensen OS, Ektor-Andersen J, Ørbæk P, Winzor G, Bültmann U, Poulsen OM.

Scand J Work Environ Health. 2012 Mar;38(2):120-33. doi: 10.5271/sjweh.3272. Epub 2012 Jan 13.

6.

Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort study.

Nielsen DS, Langdahl BL, Sørensen OH, Sørensen HA, Brixen KT.

Scand J Public Health. 2010 Jul;38(5):502-7. doi: 10.1177/1403494810371243. Epub 2010 May 19.

PMID:
20484306
7.

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ.

J Bone Miner Res. 2006 Apr;21(4):536-42. Epub 2006 Apr 5.

8.

The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats.

Jørgensen NR, Teilmann SC, Henriksen Z, Meier E, Hansen SS, Jensen JE, Sørensen OH, Petersen JS.

Endocrinology. 2005 Nov;146(11):4745-54. Epub 2005 Aug 18.

PMID:
16109789
9.

[Normal ranges and quality assurance for dual energy X-ray absorptiometry scanning].

Abrahamsen B, Sørensen HA, Rud B, Hermann AP, Jensen JE, Mølgaard C, Sørensen OH.

Ugeskr Laeger. 2005 Feb 21;167(8):878-82. Review. Danish. No abstract available.

PMID:
15789839
10.

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ.

J Clin Endocrinol Metab. 2005 May;90(5):2816-22. Epub 2005 Feb 22.

11.

Seven years of treatment with risedronate in women with postmenopausal osteoporosis.

Mellström DD, Sörensen OH, Goemaere S, Roux C, Johnson TD, Chines AA.

Calcif Tissue Int. 2004 Dec;75(6):462-8. Epub 2004 Oct 7.

PMID:
15455188
12.

Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devices.

Madsen OR, Suetta C, Egsmose C, Lorentzen JS, Sørensen OH.

Clin Rheumatol. 2004 Aug;23(4):324-9. Epub 2004 May 18.

PMID:
15293093
14.

Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.

Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sørensen OH, Eiken P, Nielsen SP, Mosekilde L.

Maturitas. 2003 Oct 20;46(2):123-32.

PMID:
14559383
15.

Standardization of BMD T-Scores in the first five years after the menopause: do femoral neck-equivalent and older normative range T-Scores improve diagnostic agreement?

Abrahamsen B, Tofteng CL, Bärenholdt O, Vestergaard P, Stilgren LS, Beck-Nielsen H, Nielsen SP, Sørensen OH, Mosekilde L; Danish Osteoporosis Prevention Study.

J Clin Densitom. 2003 Summer;6(2):87-95.

PMID:
12794230
16.

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Sorensen OH, Crawford GM, Mulder H, Hosking DJ, Gennari C, Mellstrom D, Pack S, Wenderoth D, Cooper C, Reginster JY.

Bone. 2003 Feb;32(2):120-6.

PMID:
12633783
17.

Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.

Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B, Brot C, Kolthoff N, Sørensen OH, Beck-Nielsen H, Nielsen SP, Charles P, Mosekilde L.

J Bone Miner Res. 2003 Feb;18(2):333-42.

18.

Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells.

Jørgensen NR, Teilmann SC, Henriksen Z, Civitelli R, Sørensen OH, Steinberg TH.

J Biol Chem. 2003 Feb 7;278(6):4082-6. Epub 2002 Nov 22.

20.

Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.

Sneppen SB, Hoeck HC, Kollerup G, Sørensen OH, Laurberg P, Feldt-Rasmussen U.

Eur J Endocrinol. 2002 Feb;146(2):187-95.

PMID:
11834427

Supplemental Content

Loading ...
Support Center